NSCLC, STAGE III
Clinical trials for NSCLC, STAGE III explained in plain language.
Never miss a new study
Get alerted when new NSCLC, STAGE III trials appear
Sign up with your email to follow new studies for NSCLC, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for frail lung cancer patients: targeted radiation plus immunotherapy without chemo
Disease control CompletedThis study tested a combination of chest radiation and the immunotherapy drug durvalumab in 51 elderly or frail patients with stage III lung cancer who could not tolerate chemotherapy. The goal was to see if this approach is safe and can shrink tumors. Results focused on side eff…
Matched conditions: NSCLC, STAGE III
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug cocktail shows promise for tough lung cancer
Disease control CompletedThis study tested whether adding two drugs, GFH018 and toripalimab, to standard chemoradiation helps shrink tumors in people with stage III lung cancer that cannot be removed by surgery. 65 adults with newly diagnosed, locally advanced non-small cell lung cancer took part. The ma…
Matched conditions: NSCLC, STAGE III
Phase: PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC